Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-143056

Chief Legal Officer sold 1,841 shares at $24.66 ($45,399)

  • Chief Legal Officer acquired 1,841 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ali-Jackson Kamil · Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-09-28 Exercise or conversion : show line 1 in the form +1,841 $0.72 $1,326 77,798 D
2016-09-28 Sale : show line 2 in the form −1,841 $24.66 $45,399 75,957 D
Open-market sales · 1,841 sh · avg $24.66 · $45,399

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2016-09-26 Exercise or conversion : show line 3 in the form Employee StockOption (right to buy) −1,841 2,176 D
Loading xslF345X03/doc4.xml…